Urgent.News

What's breaking now, across thousands of outlets.

Science

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping off the chemical tags that keep genes silenced and allowing those genes to switch back on.

Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Science

More from Friday 20 November →